1. |
Bledsoe TJ, Nath SK, Decker RH. Radiation pneumonitis. Clin Chest Med, 2017, 38(2): 201-208.
|
2. |
Zhang P, Yan H, Wang S, et al. Post-radiotherapy maintenance treatment with fluticasone propionate and salmeterol for lung cancer patients with grade Ⅲ radiation pneumonitis: a case report. Medicine (Baltimore), 2018, 97(21): e10681.
|
3. |
Kawakami H, Miyabayashi T, Tsubata C, et al. Spontaneous resolution of thoracic radiation therapy-induced organizing pneumonia: a case series. Respir Med Case Rep, 2019, 26: 180-184.
|
4. |
Wolf MS, Chadha AD, Carroll CM, et al. Unusual progression and subsequent improvement in cystic lung disease in a child with radiation-induced lung injury. Pediatr Radiol, 2015, 45(7): 1086-1090.
|
5. |
Conway JL, Long K, Ploquin N, et al. Unexpected symptomatic pneumonitis following breast tangent radiation: a case report. Cureus, 2015, 7(10): e363.
|
6. |
Hu Y, Li J, Su X. Fatal pneumonitis associated with postoperative intensity-modulated radiotherapy in lung cancer: case report and review. Oncol Lett, 2013, 5(2): 714-716.
|
7. |
Sakurai K, Kubo N, Shibutani M, et al. Five cases of severe radiation pneumonitis after chemoradiotherapy for esophageal cancer. Gan To Kagaku Ryoho, 2013, 40(12): 2139-2142.
|
8. |
Muraoka T, Bandoh S, Fujita J, et al. Corticosteroid refractory radiation pneumonitis that remarkably responded to cyclosporin A. Intern Med, 2002, 41(9): 730-703.
|
9. |
Bölke E, Matuschek C. Images in clinical medicine. Radiation pneumonitis after radiotherapy for breast cancer. N Engl J Med, 2009, 361(27): e65.
|
10. |
Miyagawa T, Mochizuki Y, Nakahara Y, et al. A case of severe radiation pneumonitis--a trial of plasma exchange. Nihon Kokyuki Gakkai Zasshi, 2009, 47(6): 481-485.
|
11. |
Huang Y, Zhang W, Yu F, et al. The cellular and molecular mechanism of radiation-induced lung injury. Med Sci Monit, 2017, 23: 3446-3450.
|
12. |
Torre-Bouscoulet L, Muñoz-Montaño WR, Martínez-Briseño D, et al. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer. Respir Res, 2018, 19(1): 72.
|
13. |
Guilbault C, Garant A, Faria S, et al. Long-term outcomes of induction carboplatin and gemcitabine followed by concurrent radiotherapy with low-dose paclitaxel and gemcitabine for stage Ⅲ non-small-cell lung cancer. Clin Lung Cancer, 2017, 18: 565-571.
|
14. |
Chen Z, Wu Z, Ning W. Advances in molecular mechanisms and treatment of radiation-induced pulmonary fibrosis. Transl Oncol, 2019, 12(1): 162-169.
|
15. |
Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med, 2014, 370(22): 2071-2082.
|
16. |
Distler O, Highland KB, Gahlemann M, et al. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med, 2019, 380(26): 2518-2528.
|
17. |
Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med, 2019, 381(18): 1718-1727.
|
18. |
Capelletto E, Migliorino MR, Morabito A, et al. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. Lung Cancer, 2019, 134: 210-217.
|
19. |
Forster M, Hackshaw A, De Pas T, et al. A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3). Lung Cancer, 2018, 120: 27-33.
|
20. |
Henkenberens C, Janssen S, Lavae-Mokhtari M, et al. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade Ⅱ after radiotherapy - a single-centre experience. Radiat Oncol, 2016, 11: 12.
|
21. |
Hanania AN, Mainwaring W, Ghebre YT, et al. Radiation-induced lung injury: assessment and management. Chest, 2019, 156(1): 150-162.
|
22. |
Jackson IL, Vujaskovic Z, Down JD. A further comparison of pathologies after thoracic irradiation among different mouse strains: finding the best preclinical model for evaluating therapies directed against radiation-induced lung damage. Radiat Res, 2011, 175: 510-518.
|
23. |
Otani K, Nishiyama K, Ito Y, et al. Steroid treatment increases the recurrence of radiation-induced organizing pneumonia after breast-conserving therapy. Cancer Med, 2014, 3(4): 947-953.
|
24. |
Wollin L, Distler JHW, Redente EF, et al. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J, 2019, 54(3): 1900161.
|
25. |
Jin H, Yoo Y, Kim Y, et al. Radiation-induced lung fibrosis: preclinical animal models and therapeutic strategies. Cancers (Basel), 2020, 12(6): 1561.
|
26. |
Westbury CB, Yarnold JR. Radiation fibrosis--current clinical and therapeutic perspectives. Clin Oncol (R Coll Radiol), 2012, 24(10): 657-672.
|
27. |
刘文秀, 杨娟, 曹博, 等. 甲磺酸伊马替尼对放射性肺炎小鼠肺部氧化应激指标及转化生长因子-β1 表达影响的研究. 中国呼吸与危重监护杂志, 2017, 16(5): 446-450.
|
28. |
De Ruysscher D, Granton PV, Lieuwes NG, et al. Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: a preclinical study with a high precision image-guided irradiator. Radiother Oncol, 2017, 124(3): 482-487.
|